Corbus Pharmaceuticals Holdings (STU:3371) OCF Yield %: -43.02 (As of Jul. 03, 2026)


STU:3371 Corbus Pharmaceuticals Holdings Inc STU:3371
31 GF Score
Price €8.09
! 1 Warning Sign
View Full Analysis

What is Corbus Pharmaceuticals Holdings OCF Yield %?

Corbus Pharmaceuticals Holdings STU:3371 +1.19% 31 OCF Yield % is -43.02 as of Jul. 03, 2026. GuruFocus rates STU:3371 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,414 Biotechnology companies, Corbus Pharmaceuticals Holdings ranks worse than 82.11% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Corbus Pharmaceuticals Holdings's Trailing 12-Month Cash Flow from Operations is €-63.36 Mil, and Market Cap is €150.49 Mil. Therefore, Corbus Pharmaceuticals Holdings's OCF Yield % for today is -43.02%.

The historical rank and industry rank for Corbus Pharmaceuticals Holdings's OCF Yield % or its related term are showing as below:

STU:3371' s OCF Yield % Range Over the Past 10 Years
Min: -355.12   Med: -40.02   Max: -2.09
Current: -43.02


During the past 13 years, the highest OCF Yield % of Corbus Pharmaceuticals Holdings was -2.09%. The lowest was -355.12%. And the median was -40.02%.

STU:3371's OCF Yield % is ranked worse than
82.11% of 1414 companies
in the Biotechnology industry
Industry Median: -8.155 vs STU:3371: -43.02

Corbus Pharmaceuticals Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Corbus Pharmaceuticals Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Corbus Pharmaceuticals Holdings OCF Yield % Related Terms


Corbus Pharmaceuticals Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for Corbus Pharmaceuticals Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corbus Pharmaceuticals Holdings OCF Yield % Chart

Corbus Pharmaceuticals Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65.04 -279.06 -249.39 -27.31 -45.65

Corbus Pharmaceuticals Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.78 -79.62 -41.05 -45.08 -63.13

STU:3371 vs PRQR, NRXP, CRBU: OCF Yield % Comparison

For the Biotechnology subindustry, Corbus Pharmaceuticals Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corbus Pharmaceuticals Holdings OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corbus Pharmaceuticals Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Corbus Pharmaceuticals Holdings's OCF Yield % falls into.


STU:3371
31GF Score
Corbus Pharmaceuticals Holdings Inc STU:3371
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corbus Pharmaceuticals Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Corbus Pharmaceuticals Holdings's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-55.075 / 120.6422
=-45.65%

Corbus Pharmaceuticals Holdings's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-22.119 * 4 / 140.1381
=-63.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -43.02 mean?
Corbus Pharmaceuticals Holdings (STU:3371) has a OCF Yield % of -43.02 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Corbus Pharmaceuticals Holdings and its competitors. According to the industry distribution chart, Corbus Pharmaceuticals Holdings ranks #1161 out of 1414 companies in the Biotechnology industry, placing it in the top 82.1%.
Is Corbus Pharmaceuticals Holdings' OCF Yield % too high?
Corbus Pharmaceuticals Holdings' current OCF Yield % is -43.02. Based on the distribution chart, Corbus Pharmaceuticals Holdings ranks #1161 out of 1414 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Corbus Pharmaceuticals Holdings has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Corbus Pharmaceuticals Holdings' OCF Yield % compare to PRQR and NRXP?
According to the Biotechnology industry distribution chart, Corbus Pharmaceuticals Holdings ranks #1161 out of 1414 companies for OCF Yield %. This places Corbus Pharmaceuticals Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Corbus Pharmaceuticals Holdings and its competitors. Corbus Pharmaceuticals Holdings's current OCF Yield % is -43.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corbus Pharmaceuticals Holdings stock overvalued right now?
Corbus Pharmaceuticals Holdings (STU:3371) has a current OCF Yield % of -43.02. The current OCF Yield % is -43.02. Corbus Pharmaceuticals Holdings' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Corbus Pharmaceuticals Holdings (STU:3371), the current OCF Yield % is -43.02 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corbus Pharmaceuticals Holdings Business Description

Other Exchanges CRBP:USA0SZI:UK
Address 500 River Ridge Drive, Norwood, MA, USA, 02062
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
31GF Score

Get the complete analysis for STU:3371

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.09
Price